Since 2008, the ultra-wealthy have been bidding up their own assets, deluding themselves that the fabricated valuations they place on them are real.Momentum bubble visualized:Sales / Price: The amount of revenue for each dollar invested in stocks:http://www.multpl.com/s-p-500-price-to-salesData from WSJ:One year ago, 41 private venture start-ups were valued at $1 billion or more. Now, 75 companies are valued above $1 billion. […]
Since 2008, the ultra-wealthy have been bidding up their own assets, deluding themselves that the fabricated valuations they place on them are real.Momentum bubble visualized:Sales / Price: The amount of revenue for each dollar invested in stocks:http://www.multpl.com/s-p-500-price-to-salesData from WSJ:One year ago, 41 private venture start-ups were valued at $1 billion or more. Now, 75 companies are valued above $1 billion. […]
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis.The market’s best-performing companies last week included three healthcare stocks that won over investors with can’t-miss news. Two of these companies are highly speculative, emerging-stage biotech stocks that […]
It remains a time for caution. After a brief flurry of optimism this Monday the rest of the week went quite badly. Friday the indexes opened mixed, sold off until mid day, tried to rally til mid afternoon, and then a flurry of selling into the close. Not great. The S&P 500 fell 1.30% and the NASDAQ 1.03%. A lower […]
Stock Trading Alert: Stocks Suffered Some Further Losses Following FOMC Decision ReleaseBy: Paul Rejczak | Thu, Jan 29, 2015SharePrintEmailStock Trading Alert originally published on January 29, 2015, 6:32 AM:Briefly: In our opinion, no speculative positions are justified.Our intraday outlook remains neutral, and our short-term outlook is neutral:Intraday outlook (next 24 hours): neutralShort-term outlook (next 1-2 weeks): neutralMedium-term outlook (next 1-3 […]
Industrials
Why United Parcel Service (UPS) Stock Is Trading Down By 10%
UPS stock is trading down by around 10% on Friday, following the release of expectations of disappointing fourth-quarter financial results
UPS
FDX
By: Martin BlancPublished: Jan 23, 2015 at 10:57 am EST
United Parcel Service, Inc. (NYSE:UPS) released its preliminary fourth-quarter financial results before the market opened on Friday. The company warned investors of […]
View gallery.The graphs below were produced by Capital Market Labs.A critical factor in assessing pharmaceutical and biotech companies is the quality of their drug pipelines. This is especially true as investors begin to look at the smaller companies in the space; the smaller the company, the more an investment is simply a bet on that particular pipeline.So, let’s take a look […]
Source: Celgene CorporationThe biotechnology industry has been one of the best performing baskets in the stock market this year, but just because biotech stocks were kind to investors this year doesn’t necessarily mean that they’ll rally next year, too.Biotech stocks can move significantly higher or lower in any given year due to investor’s reaction to data from ongoing drug trials, […]
Biotechnology stocks have been among the market’s top performers this year, with the iShares Nasdaq Biotechnology ETF’s 36% gain handily outpacing the S&P 500 ‘s 14% return. That heady return, however, comes with one potential drawback: It might be tough to figure out which biotech stocks will continue climbing next year. With that in mind, here are three large-cap biotech […]
Biotech stocks are infamous for their volatile ways — shooting higher one minute, only to crater the next. After a biotech crashes, investors should always assess their options going forward. Sometimes a marked sell-off represents a compelling buying opportunity that can pay off handsomely over the long run. On the other hand, a mass shareholder exodus can trigger a series of events […]
